共有 50 笔近期内部人交易记录记录，涉及 Theseus Pharmaceuticals, Inc. (THRX), 包括 39 笔买入 和 8 笔卖出. 内部人买入总额为 $29.44M 内部人卖出总额为 $4.71M.
近期活跃的重要内部人包括 Orbimed Advisors Llc, Hayden Donald J Jr, Gordon Carl L. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — THRX
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2024-02-14 |
Orbimed Advisors Llc |
10 Percent Owner |
要约收购（卖出） |
650,600 |
$4.05 |
$2.63M |
- |
| 2024-02-14 |
Hayden Donald J Jr |
Director |
股份退回 |
3,250 |
- |
- |
- |
| 2024-02-14 |
Gordon Carl L |
10 Percent Owner |
股份退回 |
3,250 |
- |
- |
- |
| 2024-02-14 |
Stein Steven H |
Director |
股份退回 |
3,250 |
- |
- |
- |
| 2024-02-14 |
Dukes Iain D. |
Director |
股份退回 |
61,549 |
$4.03 |
$248.33K |
- |
| 2024-02-14 |
Yi Kathy |
Director |
股份退回 |
99,634 |
$4.03 |
$401.99K |
- |
| 2024-02-14 |
Dahms Bradford D. |
President and CFO |
股份退回 |
332,114 |
$4.03 |
$1.34M |
- |
| 2023-11-06 |
Shakespeare William |
See Remarks |
期权行权（卖出） |
251,084 |
$0.32 |
$80.35K |
93,260 |
| 2023-07-17 |
Orbimed Advisors Llc |
10 Percent Owner |
知情买入 |
151,450 |
$3.05 |
$461.92K |
650,600 |
| 2023-07-17 |
Gordon Carl L |
10 Percent Owner |
知情买入 |
151,450 |
$3.05 |
$461.92K |
650,600 |
| 2023-07-17 |
Foresite Capital Management V, Llc |
10 Percent Owner |
知情买入 |
176,550 |
$2.97 |
$524.35K |
1,385,825 |
| 2023-06-13 |
Hayden Donald J Jr |
Director |
限制性股票授予 (RSU) |
3,250 |
- |
- |
3,250 |
| 2023-06-13 |
Gordon Carl L |
10 Percent Owner |
限制性股票授予 (RSU) |
3,250 |
- |
- |
3,250 |
| 2023-06-13 |
Stein Steven H |
Director |
限制性股票授予 (RSU) |
3,250 |
- |
- |
3,250 |
| 2023-06-13 |
Dukes Iain D. |
Director |
限制性股票授予 (RSU) |
3,250 |
- |
- |
3,250 |
| 2023-06-13 |
Yi Kathy |
Director |
限制性股票授予 (RSU) |
3,250 |
- |
- |
3,250 |
| 2023-03-01 |
Clackson Timothy P |
President and CEO |
限制性股票授予 (RSU) |
45,625 |
- |
- |
45,625 |
| 2023-03-01 |
Dahms Bradford D. |
Chief Financial Officer |
限制性股票授予 (RSU) |
17,500 |
- |
- |
17,500 |
| 2023-03-01 |
Kerstein David |
Chief Medical Officer |
限制性股票授予 (RSU) |
17,500 |
- |
- |
17,500 |
| 2023-03-01 |
Rivera Victor |
Chief Scientific Officer |
限制性股票授予 (RSU) |
16,250 |
- |
- |
16,250 |
| 2023-03-01 |
Shakespeare William |
See Remarks |
限制性股票授予 (RSU) |
21,250 |
- |
- |
21,250 |
| 2023-02-17 |
Clackson Timothy P |
President and CEO |
限制性股票授予 (RSU) |
273,750 |
$11.42 |
$3.13M |
273,750 |
| 2023-02-17 |
Dahms Bradford D. |
Chief Financial Officer |
限制性股票授予 (RSU) |
105,000 |
$11.42 |
$1.2M |
105,000 |
| 2023-02-17 |
Kerstein David |
Chief Medical Officer |
限制性股票授予 (RSU) |
105,000 |
$11.42 |
$1.2M |
105,000 |
| 2023-02-17 |
Rivera Victor |
Chief Scientific Officer |
限制性股票授予 (RSU) |
97,500 |
$11.42 |
$1.11M |
97,500 |
| 2023-02-17 |
Shakespeare William |
See Remarks |
限制性股票授予 (RSU) |
127,500 |
$11.42 |
$1.46M |
127,500 |
| 2022-12-30 |
Hayden Donald J Jr |
Director |
知情买入 |
9,900 |
$5.00 |
$49.49K |
10,000 |
| 2022-12-29 |
Hayden Donald J Jr |
Director |
知情买入 |
100 |
$5.00 |
$500.00 |
100 |
| 2022-12-29 |
Foresite Capital Management V, Llc |
Director |
知情买入 |
250,000 |
$5.00 |
$1.25M |
1,209,275 |
| 2022-11-30 |
Dahms Bradford D. |
Chief Financial Officer |
知情买入 |
1,502 |
$6.66 |
$10K |
6,142 |
| 2022-11-11 |
Clackson Timothy P |
President and CEO |
知情买入 |
2,500 |
$6.80 |
$17K |
351,030 |
| 2022-11-07 |
Orbimed Advisors Llc |
Director |
知情买入 |
192,000 |
$5.21 |
$1M |
16,734,518 |
| 2022-11-07 |
Gordon Carl L |
Director |
知情买入 |
192,000 |
$5.21 |
$1M |
16,734,518 |
| 2022-10-17 |
Stein Steven H |
Director |
未知 |
- |
- |
- |
- |
| 2022-10-17 |
Stein Steven H |
Director |
限制性股票授予 (RSU) |
60,000 |
- |
- |
60,000 |
| 2022-06-10 |
Gordon Carl L |
10 Percent Owner |
限制性股票授予 (RSU) |
30,000 |
$5.75 |
$172.5K |
30,000 |
| 2022-06-10 |
Dukes Iain D. |
Chairman |
限制性股票授予 (RSU) |
15,000 |
- |
- |
15,000 |
| 2022-06-10 |
Yi Kathy |
Director |
限制性股票授予 (RSU) |
30,000 |
- |
- |
30,000 |
| 2022-06-09 |
Foresite Capital Management V, Llc |
Director |
未知 |
- |
- |
- |
959,275 |
| 2022-05-17 |
Hayden Donald J Jr |
Director |
未知 |
- |
- |
- |
- |
| 2022-05-17 |
Hayden Donald J Jr |
Director |
限制性股票授予 (RSU) |
60,000 |
$8.02 |
$481.2K |
60,000 |
| 2022-02-18 |
Clackson Timothy P |
President and CEO |
限制性股票授予 (RSU) |
450,000 |
$11.21 |
$5.04M |
450,000 |
| 2022-02-18 |
Dahms Bradford D. |
Chief Financial Officer |
限制性股票授予 (RSU) |
150,000 |
$11.21 |
$1.68M |
150,000 |
| 2022-02-18 |
Kerstein David |
Chief Medical Officer |
限制性股票授予 (RSU) |
150,000 |
$11.21 |
$1.68M |
150,000 |
| 2022-02-18 |
Dalgarno David |
Chief Technical Officer |
限制性股票授予 (RSU) |
130,000 |
$11.21 |
$1.46M |
130,000 |
| 2022-02-18 |
Rivera Victor |
Chief Scientific Officer |
限制性股票授予 (RSU) |
130,000 |
$11.21 |
$1.46M |
130,000 |
| 2022-02-18 |
Shakespeare William |
See Remarks |
限制性股票授予 (RSU) |
180,000 |
$11.21 |
$2.02M |
180,000 |
| 2022-01-21 |
Orbimed Advisors Llc |
10 Percent Owner |
知情买入 |
111,896 |
$9.97 |
$1.12M |
16,542,652 |
| 2022-01-21 |
Gordon Carl L |
10 Percent Owner |
知情买入 |
111,896 |
$9.97 |
$1.12M |
16,542,652 |
| 2022-01-20 |
Orbimed Advisors Llc |
10 Percent Owner |
知情买入 |
35,000 |
$9.95 |
$348.25K |
16,430,756 |
■ 知情交易 — 公开市场买卖（最具参考价值）
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期
